Cancers

Multidisciplinary Digital Publishing Institute (MDPI) · Switzerland · Est. 1887

ISSN2072-6694eISSN2072-6694

SJR Q1✓ WOS SCIE✓ Scopus / SJR

Removed from DOAJ (2024-09-06). DOAJ's stated reason: Journal not adhering to Best practice. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

1.41

H-Indexi

217

SNIPi

1.114

Total Worksi

35,907

Total Citationsi

761,193

2yr Mean Citednessi

4.08

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Cancers publishes research on the molecular and cellular components of the cancer microenvironment. It also includes studies on cognitive impairment in patients with glioma, focusing on mechanisms, assessment methods, and therapies. Additionally, the journal covers outcomes of anatomical versus non-anatomical pulmonary metastasectomy.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published1887

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications35,907

Publisher OrgMultidisciplinary Digital Publishing Institute

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Multidisciplinary Digital Publishing Institute (MDPI)

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2072-6694 / 2072-6694

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2.1k

106k

2019

3.9k

148k

2020

6.5k

187k

2021

6.4k

133k

2022

5.8k

89k

2023

4.2k

38k

2024

4.1k

17k

2025

2.6k

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ1

Cancer ResearchQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsCancer Cells and MetastasisPancreatic and Hepatic Oncology ResearchGlioma Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingCancer, Hypoxia, and MetabolismEpigenetics and DNA MethylationHepatocellular Carcinoma Treatment and PrognosisImmunotherapy and Immune Responses

Frequently asked questions about Cancers

Is Cancers a predatory journal?

Cancers was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal not adhering to Best practice" (2024-09-06). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Cancers?

Cancers is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.08.

Is Cancers indexed in Scopus and Web of Science?

Cancers is indexed in Web of Science, Scopus.